Adicet Bio Stock Filter Stocks by Fundamentals
ACET Stock | USD 0.82 0.07 9.33% |
Adicet Bio's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Adicet Stock price.
Adicet | Shares Owned by Institutions | Build AI portfolio with Adicet Stock |
Adicet Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Adicet Bio from analyzing Adicet Bio's financial statements. These drivers represent accounts that assess Adicet Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Adicet Bio's important valuation drivers and their relationship over time.
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Market Cap | 102.8M | 541.4M | 367.3M | 81.4M | 84.5M | 80.3M | |
Enterprise Value | 40.2M | 284.8M | 130.6M | (57.4M) | 45.3M | 43.0M |
Adicet Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Adicet Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Adicet Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Adicet Bio's value.Shares | Regeneron Pharmaceuticals Inc | 2025-03-31 | 968.2 K | Bridgeway Capital Management, Llc | 2025-03-31 | 901.6 K | Renaissance Technologies Corp | 2025-03-31 | 810.7 K | Geode Capital Management, Llc | 2025-03-31 | 770.7 K | Blackrock Inc | 2025-03-31 | 749.1 K | Alyeska Investment Group, L.p. | 2025-03-31 | 655.7 K | Two Sigma Advisers, Llc | 2025-03-31 | 622.8 K | Rbf Llc | 2025-03-31 | 617.3 K | Dafna Capital Management Llc | 2025-03-31 | 600 K | Orbimed Advisors, Llc | 2025-03-31 | 11.4 M | Tang Capital Management Llc | 2025-03-31 | 8.2 M |
Adicet Fundamentals
Return On Equity | -0.56 | ||||
Return On Asset | -0.33 | ||||
Current Valuation | (72.99 M) | ||||
Shares Outstanding | 82.71 M | ||||
Shares Owned By Insiders | 2.80 % | ||||
Shares Owned By Institutions | 67.41 % | ||||
Number Of Shares Shorted | 3.32 M | ||||
Price To Earning | 36.84 X | ||||
Price To Book | 0.38 X | ||||
Price To Sales | 9.72 X | ||||
Gross Profit | 24.99 M | ||||
EBITDA | (110.65 M) | ||||
Net Income | (117.12 M) | ||||
Cash And Equivalents | 260.64 M | ||||
Cash Per Share | 6.11 X | ||||
Total Debt | 17.23 M | ||||
Debt To Equity | 0.08 % | ||||
Current Ratio | 16.10 X | ||||
Book Value Per Share | 1.95 X | ||||
Cash Flow From Operations | (92.38 M) | ||||
Short Ratio | 8.40 X | ||||
Earnings Per Share | (1.29) X | ||||
Price To Earnings To Growth | 0.82 X | ||||
Target Price | 6.0 | ||||
Number Of Employees | 152 | ||||
Beta | 1.6 | ||||
Market Capitalization | 62.2 M | ||||
Total Asset | 220.22 M | ||||
Retained Earnings | (497.89 M) | ||||
Working Capital | 160.74 M | ||||
Current Asset | 352.66 M | ||||
Current Liabilities | 98.91 M | ||||
Five Year Return | 3.23 % | ||||
Net Asset | 220.22 M |
About Adicet Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adicet Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adicet Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adicet Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Adicet Stock Analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.